‘Dose Dense’ Chemo Improves Survival in Breast Cancer Patients

A new clinical trial has shown that reducing the interval between successive doses of a commonly used chemotherapy regimen improves survival in women whose breast cancer has spread to the lymph nodes. While previous research has evaluated the use of various forms of “dose dense” chemotherapy, this is the first major controlled study to show a clear survival benefit for women with node-positive breast cancer.

Get more stuff like this
in your inbox

From anti-aging to the search for alien life, we promise to never bore.